Relationship between two forms of impulsivity in mice at baseline and under acute and sub-chronic atomoxetine treatment
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Relationship between two forms of impulsivity in mice at baseline and under acute and sub-chronic atomoxetine treatment. / Kyriakidou, Maria; Caballero-Puntiverio, Maitane; Andreasen, Jesper T.; Thomsen, Morgane.
In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 127, 110841, 2023.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Relationship between two forms of impulsivity in mice at baseline and under acute and sub-chronic atomoxetine treatment
AU - Kyriakidou, Maria
AU - Caballero-Puntiverio, Maitane
AU - Andreasen, Jesper T.
AU - Thomsen, Morgane
N1 - Publisher Copyright: © 2023 The Authors
PY - 2023
Y1 - 2023
N2 - Rationale: Impulsivity is a symptom of various mental disorders, including attention deficit hyperactivity disorder (ADHD), bipolar disorder, and addiction. Impulsivity is not a unitary construct, but is present in different forms, yet only a few rodent studies have explored the relationship between these forms within individual subjects. Objectives: In this study, we compared behaviors representing two impulsivity forms, delay discounting (choice impulsivity) and premature responding (waiting impulsivity), within the same mice. Methods: C57BL/6J male mice were concurrently trained and tested in the delay discounting task and the rodent continuous performance test in a counterbalanced design. The effects of the ADHD medication atomoxetine were tested in both tasks, after both acute (0.3–5.0 mg/kg) and sub-chronic (0.3 mg/kg twice daily for seven days) administration. Results: There was no correlation between the two impulsivity forms at baseline. Acute atomoxetine treatment (1, 3, and 5 mg/kg) significantly reduced premature responding. Furthermore, sub-chronic treatment with 0.3 mg/kg of atomoxetine caused a stable decrease in premature responding. Atomoxetine had no significant effect on delay discounting after acute or sub-chronic administration, although the acute administration of 1 mg/kg showed a trend towards increasing delay discounting. Conclusions: The present results support that delay discounting and premature responding represent two different forms of impulsivity that show dissimilar responses to atomoxetine treatment. The consistency with findings in humans lends support to the translatability of the results in mice.
AB - Rationale: Impulsivity is a symptom of various mental disorders, including attention deficit hyperactivity disorder (ADHD), bipolar disorder, and addiction. Impulsivity is not a unitary construct, but is present in different forms, yet only a few rodent studies have explored the relationship between these forms within individual subjects. Objectives: In this study, we compared behaviors representing two impulsivity forms, delay discounting (choice impulsivity) and premature responding (waiting impulsivity), within the same mice. Methods: C57BL/6J male mice were concurrently trained and tested in the delay discounting task and the rodent continuous performance test in a counterbalanced design. The effects of the ADHD medication atomoxetine were tested in both tasks, after both acute (0.3–5.0 mg/kg) and sub-chronic (0.3 mg/kg twice daily for seven days) administration. Results: There was no correlation between the two impulsivity forms at baseline. Acute atomoxetine treatment (1, 3, and 5 mg/kg) significantly reduced premature responding. Furthermore, sub-chronic treatment with 0.3 mg/kg of atomoxetine caused a stable decrease in premature responding. Atomoxetine had no significant effect on delay discounting after acute or sub-chronic administration, although the acute administration of 1 mg/kg showed a trend towards increasing delay discounting. Conclusions: The present results support that delay discounting and premature responding represent two different forms of impulsivity that show dissimilar responses to atomoxetine treatment. The consistency with findings in humans lends support to the translatability of the results in mice.
KW - Atomoxetine
KW - Delay discounting
KW - Impulsivity
KW - Impulsivity forms
KW - Premature responding
KW - Rodent continuous performance test
U2 - 10.1016/j.pnpbp.2023.110841
DO - 10.1016/j.pnpbp.2023.110841
M3 - Journal article
C2 - 37586638
AN - SCOPUS:85168817737
VL - 127
JO - Progress in Neuro-Psychopharmacology & Biological Psychiatry
JF - Progress in Neuro-Psychopharmacology & Biological Psychiatry
SN - 0278-5846
M1 - 110841
ER -
ID: 366301445